Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-029715
Filing Date
2025-03-31
Accepted
2025-03-31 10:47:52
Documents
1
Period of Report
2025-03-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2510904-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2510904-1_4seq1.xml 4 9083
  Complete submission text file 0001104659-25-029715.txt   10501
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SILENCE THERAPEUTICS INC. 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address
Griffiths Richard Ian (Reporting) CIK: 0001846370 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 25789963